Page last updated: 2024-08-21

quinazolines and doxazosin

quinazolines has been researched along with doxazosin in 72 studies

Research

Studies (72)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (13.89)	18.7374
1990's	7 (9.72)	18.2507
2000's	31 (43.06)	29.6817
2010's	21 (29.17)	24.3611
2020's	3 (4.17)	2.80

Authors

Authors	Studies
Leren, TP	1
Ramage, AG	1
Ali, FK; Kwa, HY; Timmermans, PB; van Zwieten, PA	1
Elliott, HL; McLean, K; Meredith, PA; Reid, JL; Sumner, DJ	1
Birkenhäger, WH; de Leeuw, PW; Ligthart, JJ; Smout, AJ	1
Elliott, HL; Meredith, PA; Reid, JL; Vincent, J	1
Downing, OA; Wilson, KA; Wilson, VG	1
Hernandez, J; Prichard, BN; Saxton, CA; Singleton, W	1
Ali, FK; Kossen, SP; Timmermans, PB; Van Zwieten, PA	1
Brunton, J; Meredith, P; Rubin, PC	1
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG	1
Chalmers, DH; Kenny, BA; Miller, AM; Naylor, AM; O'Connell, J; Williamson, IJ	1
Andersson, KE; Lepor, H; Wyllie, MG	1
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I	1
Chapple, CR	1
Djavan, B; Marberger, M	1
Fu, SX; Li, YS; Ren, LM; Wu, ZJ; Yang, ZH	1
Clifford, GM; Farmer, RD	1
Cotecchia, S; Goepel, M; Hein, P; Michel, MC	1
Clementi, G; Costantino, G; Matera, M	1
Altenbach, RJ; Bai, H; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Hancock, AA; Kerwin, JF; Lebold, SA; Lee, E; Meyer, MD; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD	1
Dutkiewics, S	1
Benning, CM; Kyprianou, N	1
Kirby, RS; Pool, JL	1
Niu, CQ; Ren, LM	1
Doherty, AP	1
Anglin, IE; Kyprianou, N; Partin, JV	1
Romics, I	1
Kyprianou, N; Tahmatzopoulos, A	1
Brown, GA; Sussman, DO	1
de Reijke, TM; Klarskov, P	1
Kyprianou, N; Rowland, RG; Tahmatzopoulos, A	1
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E	1
Afshari, NA; Schwinn, DA	1
Irani, J	1
Michel, MC; Noguchi, Y; Ohtake, A; Okutsu, H; Sasamata, M; Someya, A; Suzuki, M; Ukai, M; Watanabe, M; Yanai-Inamura, H; Yuyama, H	1
de la Rosette, JJ; Michel, MC; van Dijk, MM	1
O'Leary, MP	1
Awan, MA; Cheung, CM; Peh, KK; Sandramouli, S	1
Albo, G; Berardi, F; Colabufo, NA; Contino, M; de Rienzo, G; Niso, M; Pagliarulo, A; Pagliarulo, V; Perrone, R	1
Chen, CS; Garrison, JB; Kyprianou, N; Shaw, YJ	1
Heaney, AP	1
Chen, WP; Lee, AS; Su, MJ	1
Arikan, G; Bozkurt, O; Demir, O; Durak, I; Esen, A; Saatci, AO; Yaman, A	1
Mamalis, N	1
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ	1
Hoyano, Y; Kobayashi, S; Kusama, H; Maruyama, K; Tomiyama, Y; Yamazaki, Y	1
Kyprianou, N; Michel, MC; Vaughan, TB	1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA	1
Chung, BH; Lee, SH; Mah, SY; Park, KK	1
Chatziralli, IP; Sergentanis, TN	1
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H	1
Calleja Aguayo, E; Delgado Alvira, R; Gracia Romero, J; Rihuete Heras, MA; Ruiz de Temiño Bravo, M	1
Du, H; He, L; Ren, J; Wang, S	1
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW	1
Liu, Y; Mao, C; Qin, X; Yang, K; Yang, Z; Yuan, J	1
Ahmed, S; El Zohny, SA; Mohamed, NA	1
Hassoun, G; Kedem, E; Nassar, L; Shahar, E	1
Fisher, E; Omar, MI; Subramonian, K	1
Chang, Y; Du, L; Fu, Y; Gao, N; Guo, X; Wu, H; Zhang, L	1
Barkin, J; Berner, T; Diles, D; Franks, B	1
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P	1
Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C	1
Battastini, AM; Coelho, BP; de Quadros, AH; Gaelzer, MM; Gonçalves, CA; Guerra, MC; Guma, FC; Hoppe, JB; Salbego, CG; Setton-Avruj, P; Terra, SR; Usach, V	1
Derayea, SM; Hammad, MA; Mohamed, AA; Mohamed, AI; Omar, MA	1
Afsar Yildirim, M; Akdeniz, F; Bozkurt, O; Çelik, S; Demir, O; Gursoy Bulut, M; Hacihasanoglu, ML	1
Hammad, MA; Omar, MA; Salman, BI	1
Bourdoumis, A; Buchholz, N; Dräger, D; Durner, L; Füllhase, C; Hakenberg, OW	1
Hori, Y; Ohyama, K; Sugiura, M	1
Hanna, J; Li, Y; Orahoske, CM; Petty, A; Salem, FM; Su, B; Wang, B; Zhang, W	1
Dahm, P; Hwang, EC; Koziarz, A; Kuntz, GM; Oestreich, MC; Sathianathen, NJ; Scales, CD; Vernooij, RW	1
Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ	1

Reviews

19 review(s) available for quinazolines and doxazosin

Article	Year
Prostatic alpha 1-adrenoceptors and uroselectivity. The Prostate, 1997, Feb-15, Volume: 30, Issue:3 Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Male; Prazosin; Prostate; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1997
[Alpha blockers in the treatment of benign hyperplasia of the prostate]. Revista clinica espanola, 1997, Volume: 197, Issue:5 Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1997
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade. British journal of urology, 1998, Volume: 81 Suppl 1 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1998
A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction. European urology, 1999, Volume: 36, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Controlled Clinical Trials as Topic; Dizziness; Dose-Response Relationship, Drug; Doxazosin; Humans; Hypotension, Orthostatic; Male; Middle Aged; Prazosin; Prognosis; Prostatic Hyperplasia; Quinazolines; Treatment Outcome; Urologic Diseases	1999
Medical therapy for benign prostatic hyperplasia: a review of the literature. European urology, 2000, Volume: 38, Issue:1 Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2000
Clinical significance of alpha1-adrenoceptor selectivity in the management of benign prostatic hyperplasia. International urology and nephrology, 2001, Volume: 33, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Blood-Brain Barrier; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Receptors, Adrenergic, alpha-1	2001
[Pharmacologic treatment of benign prostatic hyperplasia]. Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2003
Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality? The Prostate, 2004, Apr-01, Volume: 59, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Quinazolines	2004
The role of alpha-blockers in the management of prostate cancer. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiogenesis Inhibitors; Anoikis; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Sulfonamides; Tamsulosin	2004
Effects of alpha(1)-adrenoceptor antagonists on male sexual function. Drugs, 2006, Volume: 66, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Antagonists; Adult; Aged; Doxazosin; Ejaculation; Erectile Dysfunction; Humans; Libido; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2006
Treatment and pharmacologic management of BPH in the context of common comorbidities. The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2006
Targeting pituitary tumors. Hormone research, 2007, Volume: 68 Suppl 5 Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Drug Therapy, Combination; Humans; Ligands; Neoplasm Proteins; Pituitary Neoplasms; PPAR gamma; Quinazolines; Receptors, Estrogen; Receptors, Retinoic Acid; Securin	2007
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?]. Harefuah, 2008, Volume: 147, Issue:6 Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2008
Risk factors for intraoperative floppy iris syndrome: a meta-analysis. Ophthalmology, 2011, Volume: 118, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin	2011
The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews. Current medical research and opinion, 2013, Volume: 29, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2013
The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. The Cochrane database of systematic reviews, 2014, Jun-10, Issue:6 Topics: Acute Disease; Adrenergic alpha-Antagonists; Adult; Device Removal; Doxazosin; Humans; Indoles; Male; Quinazolines; Randomized Controlled Trials as Topic; Recovery of Function; Sulfonamides; Tamsulosin; Urinary Catheterization; Urinary Retention; Urination	2014
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies. European urology, 2016, Volume: 69, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics	2016
The Evidence Paradox of the Effectiveness between the Paediatric and Adult Stone-Forming Population: A Narrative Review. Urologia internationalis, 2019, Volume: 102, Issue:2 Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Age of Onset; Child; Doxazosin; Evidence-Based Medicine; Female; Humans; Male; Quinazolines; Remission Induction; Tamsulosin; Treatment Outcome; Urolithiasis; Urological Agents	2019
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults. The Cochrane database of systematic reviews, 2020, 11-12, Volume: 11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxazosin; Humans; Indoles; Kidney Calculi; Lithotripsy; Middle Aged; Prazosin; Quinazolines; Randomized Controlled Trials as Topic; Tamsulosin; Ureteral Calculi	2020

Trials

6 trial(s) available for quinazolines and doxazosin

Article	Year
A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects. British journal of clinical pharmacology, 1982, Volume: 13, Issue:5 Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Heart Rate; Humans; Kinetics; Male; Prazosin; Quinazolines	1982
Within patient comparison of prazosin and UK-33,274. A new alpha-adrenoceptor-antagonist. European journal of clinical pharmacology, 1982, Volume: 23, Issue:5 Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Doxazosin; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Posture; Prazosin; Quinazolines; Time Factors	1982
Doxazosin, an alpha 1-adrenoceptor antagonist: pharmacokinetics and concentration-effect relationships in man. British journal of clinical pharmacology, 1983, Volume: 15, Issue:6 Topics: Adrenergic alpha-Antagonists; Adult; Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Half-Life; Heart Rate; Humans; Kinetics; Male; Phenylephrine; Prazosin; Quinazolines	1983
Postjunctional selectivity of alpha-blockade with prazosin, trimazosin, and UK-33,274 in man. Journal of cardiovascular pharmacology, 1982, Volume: 4 Suppl 1 Topics: Adrenergic alpha-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Double-Blind Method; Doxazosin; Heart Rate; Humans; Male; Norepinephrine; Phenylephrine; Piperazines; Prazosin; Quinazolines	1982
[Long-term therapy of benign prostatic hyperplasia. Our experience]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2001, Volume: 53, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Finasteride; Follow-Up Studies; Humans; Male; Mepartricin; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quinazolines; Time Factors	2001
Comparative efficacy of two alpha-adrenoreceptor antagonists, doxazosin and alfuzosin, in patients with lower urinary tract symptoms from benign prostatic enlargement. BJU international, 2004, Volume: 93, Issue:6 Topics: Adrenergic alpha-Antagonists; Double-Blind Method; Doxazosin; Drug Administration Schedule; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Treatment Outcome; Urination Disorders; Urodynamics	2004

Other Studies

47 other study(ies) available for quinazolines and doxazosin

Article	Year
Doxazosin increases low density lipoprotein receptor activity. Acta pharmacologica et toxicologica, 1985, Volume: 56, Issue:3 Topics: Adrenergic alpha-Antagonists; Cell Line; Cells, Cultured; Child, Preschool; Doxazosin; Fibroblasts; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Prazosin; Quinazolines; Receptors, Cell Surface; Receptors, Lipoprotein	1985
A comparison of the effects of doxazosin and alfuzosin with those of urapidil on preganglionic sympathetic nerve activity in anaesthetised cats. European journal of pharmacology, 1986, Oct-07, Volume: 129, Issue:3 Topics: Action Potentials; Animals; Blood Pressure; Cats; Doxazosin; Male; Piperazines; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Sympathetic Nervous System; Vascular Resistance	1986
Prazosin and its analogues UK-18,596 and UK-33,274: a comparative study on cardiovascular effects and alpha-adrenoceptor blocking activities. Archives internationales de pharmacodynamie et de therapie, 1980, Volume: 245, Issue:2 Topics: Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Blood Pressure; Clonidine; Doxazosin; Heart Rate; Hemodynamics; Hexobarbital; Injections, Intraventricular; Male; Phenylephrine; Prazosin; Quinazolines; Rats	1980
Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin. British journal of pharmacology, 1983, Volume: 80, Issue:2 Topics: Adrenergic alpha-Antagonists; Animals; Aorta; Calcium; Dose-Response Relationship, Drug; Doxazosin; In Vitro Techniques; Male; Norepinephrine; Prazosin; Quinazolines; Rats; Rats, Inbred Strains; Vasoconstriction; Vasodilator Agents	1983
Effects of prazosin and two of its derivatives (UK 18.596 and UK 33.274) on alpha-adrenoceptors [proceedings]. British journal of pharmacology, 1980, Volume: 68, Issue:1 Topics: Animals; Cats; Doxazosin; Prazosin; Quinazolines; Rats; Receptors, Adrenergic; Receptors, Adrenergic, alpha	1980
Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection. Journal of chromatography, 1980, Nov-14, Volume: 221, Issue:1 Topics: Chromatography, High Pressure Liquid; Doxazosin; Humans; Hypotension; Prazosin; Quinazolines; Vasodilator Agents	1980
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology, 1994, Volume: 44, Issue:1 Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin	1994
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies. British journal of pharmacology, 1996, Volume: 118, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Prazosin; Pressure; Prostate; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1996
Selective effects of alfuzosin and doxazosin with intraduodenal administration on urethral pressure of cats. Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1999, Volume: 20, Issue:5 Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cats; Doxazosin; Electric Stimulation; Hypogastric Plexus; Infusions, Intravenous; Male; Pressure; Quinazolines; Urethra	1999
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors. Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium	2001
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 2001, Jun-07, Volume: 44, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Dogs; Doxazosin; Drug Design; Humans; Indicators and Reagents; Indoles; Isoindoles; L Cells; Male; Mice; Models, Molecular; Molecular Conformation; Prazosin; Prostate; Prostatic Hyperplasia; Quinazolines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Spleen; Structure-Activity Relationship; Vas Deferens	2001
Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia. International urology and nephrology, 2001, Volume: 32, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2001
Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action. Cancer research, 2002, Jan-15, Volume: 62, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tumor Cells, Cultured	2002
[Chiral separation and preparation of three new antagonists of alpha 1-adrenoceptors by chiral mobile phase HPLC]. Yao xue xue bao = Acta pharmaceutica Sinica, 2002, Volume: 37, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Chromatography, High Pressure Liquid; Doxazosin; Molecular Structure; Prazosin; Quinazolines	2002
Benign prostatic hyperplasia. Hospital medicine (London, England : 1998), 2003, Volume: 64, Issue:2 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Finasteride; Humans; Male; Prostatic Hyperplasia; Quinazolines	2003
Quinazoline-based alpha 1-adrenoceptor antagonists induce prostate cancer cell apoptosis via TGF-beta signalling and I kappa B alpha induction. British journal of cancer, 2003, May-19, Volume: 88, Issue:10 Topics: Adrenergic alpha-Antagonists; AMP-Activated Protein Kinase Kinases; Apoptosis; Caspase 3; Caspases; Doxazosin; Gene Expression Regulation, Neoplastic; Humans; Male; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Quinazolines; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta	2003
A current review of medical therapy for benign prostatic hyperplasia. The Journal of the American Osteopathic Association, 2004, Volume: 104, Issue:2 Suppl 2 Topics: Adrenergic alpha-Antagonists; Algorithms; Azasteroids; Cholestenone 5 alpha-Reductase; Doxazosin; Drug Therapy, Combination; Dutasteride; Finasteride; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Urination Disorders	2004
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics	2004
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg? Ophthalmology, 2005, Volume: 112, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2005
Are all alpha-blockers created the same? European urology, 2006, Volume: 49, Issue:3 Topics: Adrenergic alpha-Antagonists; Adult; Clinical Trials as Topic; Dizziness; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2006
In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits. Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 372, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dose-Response Relationship, Drug; Doxazosin; Male; Prazosin; Pupil; Quinazolines; Rabbits; Receptors, Adrenergic, alpha-1; Time Factors; Urethra	2006
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist. American journal of ophthalmology, 2007, Volume: 143, Issue:6 Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cataract Extraction; Doxazosin; Female; Humans; Hypertension; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2007
Human epididymal and prostatic tracts of vas deferens: different contraction response to noradrenaline stimulation in isolated organ bath assay. European journal of pharmacology, 2007, Dec-22, Volume: 577, Issue:1-3 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Aged; Dose-Response Relationship, Drug; Doxazosin; Epididymis; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Norepinephrine; Organ Specificity; Prazosin; Prostate; Quinazolines; Stimulation, Chemical; Vas Deferens	2007
Novel quinazoline-based compounds impair prostate tumorigenesis by targeting tumor vascularity. Cancer research, 2007, Dec-01, Volume: 67, Issue:23 Topics: Adrenergic alpha-Antagonists; Animals; Apoptosis; Blotting, Western; Cell Adhesion; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Chickens; Chorioallantoic Membrane; Doxazosin; Endothelium, Vascular; Humans; Integrin beta1; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Prostatic Neoplasms; Quinazolines; Umbilical Veins	2007
Comparison of the cardiac electrophysiological effects between doxazosin and bunazosin. Journal of biomedical science, 2008, Volume: 15, Issue:4 Topics: Animals; Arrhythmias, Cardiac; Cardiac Electrophysiology; Doxazosin; Drug-Related Side Effects and Adverse Reactions; Heart; In Vitro Techniques; Ion Channels; Quinazolines; Rats	2008
The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation. Annals of ophthalmology (Skokie, Ill.), 2008,Spring, Volume: 40, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2008
Intraoperative floppy-iris syndrome associated with systemic alpha blockers. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2008
Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi, 2009, Volume: 45, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cricetinae; Doxazosin; Indoles; Male; Mesocricetus; Mice; Mice, Inbred ICR; Muscle Contraction; Norepinephrine; Prazosin; Quinazolines; Ureter	2009
Apoptosis induction by doxazosin and other quinazoline alpha1-adrenoceptor antagonists: a new mechanism for cancer treatment? Naunyn-Schmiedeberg's archives of pharmacology, 2009, Volume: 380, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Doxazosin; Humans; Neoplasms; Quinazolines	2009
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. The Journal of urology, 2010, Volume: 183, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin	2010
Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension. Prostate cancer and prostatic diseases, 2010, Volume: 13, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Drug Combinations; Humans; Hypertension; Male; Middle Aged; Models, Biological; Polypharmacy; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2010
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia. Urology, 2011, Volume: 77, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography	2011
[Our experience with the use of alpha-lithic therapy in the treatment of voiding dysfunction]. Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica, 2010, Volume: 23, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Child; Child, Preschool; Doxazosin; Female; Humans; Male; Quinazolines; Retrospective Studies; Urination Disorders	2010
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions. Analytical and bioanalytical chemistry, 2011, Volume: 400, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2011
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes. Journal of pharmacy practice, 2012, Volume: 25, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2012
Rapid and sensitive online determination of some selective α1-blockers by flow injection analysis with micelle-enhanced fluorescence detection. Journal of fluorescence, 2013, Volume: 23, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Flow Injection Analysis; Fluorescence; Internet; Micelles; Prazosin; Quinazolines; Spectrometry, Fluorescence; Time Factors	2013
Alpha-1 adrenergic antagonists induced severe rhinitis in patients with benign prostatic hyperplasia. Current drug safety, 2014, Volume: 9, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cerebrospinal Fluid Rhinorrhea; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Rhinitis	2014
Mixed micelle cloud point-magnetic dispersive μ-solid phase extraction of doxazosin and alfuzosin. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2015, Jan-05, Volume: 134 Topics: Calibration; Doxazosin; Humans; Hydrogen-Ion Concentration; Limit of Detection; Magnetic Phenomena; Magnetite Nanoparticles; Micelles; Quinazolines; Sodium Chloride; Sodium Dodecyl Sulfate; Solid Phase Extraction; Solvents; Spectrophotometry, Ultraviolet; Surface-Active Agents; Temperature	2015
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence. The Canadian journal of urology, 2015, Volume: 22, Issue:4 Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate	2015
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines. The Prostate, 2016, Volume: 76, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin	2016
Phosphatidylinositol 3-Kinase/AKT Pathway Inhibition by Doxazosin Promotes Glioblastoma Cells Death, Upregulation of p53 and Triggers Low Neurotoxicity. PloS one, 2016, Volume: 11, Issue:4 Topics: Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Brain Neoplasms; Caspase 3; Cell Line, Tumor; Cell Proliferation; Chromones; Doxazosin; Enzyme Activation; G1 Phase Cell Cycle Checkpoints; Glioblastoma; Glycogen Synthase Kinase 3 beta; Hippocampus; Humans; Lapatinib; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Rats, Wistar; Tumor Suppressor Protein p53	2016
An efficient spectrofluorimetric method adopts doxazosin, terazosin and alfuzosin coupling with orthophthalaldehyde: Application in human plasma. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2018, Apr-15, Volume: 195 Topics: Doxazosin; Fluorescence; Humans; Limit of Detection; o-Phthalaldehyde; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence	2018
Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2018, Jun-30, Volume: 90, Issue:2 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Doxazosin; Female; Flank Pain; Humans; Indoles; Male; Middle Aged; Quinazolines; Retrospective Studies; Tadalafil; Tamsulosin; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Calculi; Urological Agents; Young Adult	2018
Micellar enhanced spectrofluorimetric approach for nanogram detection of certain α Luminescence : the journal of biological and chemical luminescence, 2018, Volume: 33, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Antihypertensive Agents; Doxazosin; Fluorescence; Humans; Limit of Detection; Micelles; Pharmaceutical Preparations; Plasma; Prazosin; Quinazolines; Spectrometry, Fluorescence; Tablets	2018
Evaluation of syncope association with α Die Pharmazie, 2019, 12-01, Volume: 74, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin	2019
Dimeric small molecule agonists of EphA2 receptor inhibit glioblastoma cell growth. Bioorganic & medicinal chemistry, 2020, 09-15, Volume: 28, Issue:18 Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Proliferation; Dimerization; Doxazosin; Drug Screening Assays, Antitumor; Glioblastoma; Humans; Hydrocarbons, Aromatic; Molecular Structure; Polyethylene Glycols; Protein Binding; Quinazolines; Receptor, EphA2; Structure-Activity Relationship; Substrate Specificity	2020
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease. JAMA neurology, 2021, 04-01, Volume: 78, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States	2021